Skip to main content

    frogs

    Analyze compound-target annotations and gene signatures to connect molecules with pathway activity.

    frogs

    Connect molecules to biology by integrating compound-target annotations with gene expression signatures to score how compounds modulate biological pathways. Reach for frogs when you have hits or candidates and want mechanism-of-action insight, pathway-based prioritization, or repositioning hypotheses rather than raw binding data. It sits downstream of screening and generative chemistry, translating molecular targets into pathway-level effects. See the Cell & Tissue overview for where this fits.

    Not available in chat

    FRoGS is deprecated on the platform and its Modal backend has been taken offline — it is not registered with the orchestrator, so chat cannot call it. A still-registered legacy form of the tool also faked its results (returning mock predictions and reporting SUCCESS regardless of input), so treat any historical FRoGS output as unverified. There is no direct replacement on the platform for compound-target deconvolution from gene expression signatures.

    frogs pathway analysis integration in .bloom* platform

    frogs provides comprehensive pathway impact analysis by integrating compound-target interactions with gene expression signatures. Through .bloom*'s webapp, you can analyze how compounds modulate biological pathways and prioritize candidates based on mechanism-of-action insights.

    Citations

    Chen H, King FJ, Zhou B, Wang Y, Canedy CJ, Hayashi J, Zhong Y, Chang MW, Pache L, Wong JL, Jia Y, Joslin J, Jiang T, Benner C, Chanda SK, Zhou Y. Drug target prediction through deep learning functional representation of gene signatures. Nat Commun. 2024;15:1853. doi: 10.1038/s41467-024-46089-y

    Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005 Oct 25;102(43):15545-50. doi: 10.1073/pnas.0506580102

    Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Research. 2000 Jan 1;28(1):27-30. doi: 10.1093/nar/28.1.27

    Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. Nature Genetics. 2000 May;25(1):25-9. doi: 10.1038/75556

    Resources

    Webapp pathway analysis capabilities

    Input data integration

    Compound-target data:

    • Direct upload: CSV files with compound-target annotations
    • Previous jobs: Integration with screening results and predictions
    • Database integration: PubChem, ChEMBL, and custom target databases
    • Batch processing: Multiple compounds with associated targets

    Gene signature data:

    • Expression profiles: Differential gene expression signatures
    • Pathway databases: GO, KEGG, Reactome, and custom pathways
    • Target annotations: Gene targets associated with compounds
    • Multi-omics data: Integration of transcriptomics and proteomics

    Analysis methodology

    Signature embedding:

    • Gene expression: Transform expression profiles into pathway signatures
    • Target mapping: Link compound targets to biological pathways
    • Pathway scoring: Calculate compound impact on pathway activity
    • Mechanism inference: Identify likely modes of action

    Pathway impact assessment:

    • Enrichment analysis: Statistical assessment of pathway modulation
    • Compound ranking: Prioritization based on pathway relevance
    • Target-pathway mapping: Connect molecular targets to biological effects
    • Confidence scoring: Reliability assessment of predictions

    When to use frogs in drug discovery

    Mechanism-of-action studies

    Target deconvolution:

    • Identify pathways modulated by hit compounds
    • Understand off-target effects and polypharmacology
    • Link phenotypic screening to molecular mechanisms
    • Generate hypotheses for compound optimization

    Compound prioritization:

    • Rank compounds based on pathway selectivity
    • Identify compounds targeting therapeutically relevant pathways
    • Assess safety implications through pathway analysis
    • Guide selection of compounds for preclinical studies

    Drug repositioning:

    • Identify new indications for known compounds
    • Analyze pathway effects across different therapeutic areas
    • Compare compound profiles with approved drugs
    • Generate mechanistic hypotheses for repurposing

    Systems pharmacology applications

    Network pharmacology:

    • Analyze compound effects on biological networks
    • Identify key nodes and pathways in disease mechanisms
    • Assess compound combinations and synergistic effects
    • Model complex drug-target-pathway relationships

    Toxicity prediction:

    • Identify potential toxicity pathways and mechanisms
    • Assess off-target liabilities through pathway analysis
    • Predict adverse event profiles based on pathway modulation
    • Generate safety hypotheses for preclinical testing

    Webapp interface and workflow

    Data preparation and upload

    Compound data:

    • Upload compound lists with target annotations
    • Validate compound identifiers and target information
    • Preview data structure and completeness
    • Handle missing data and formatting issues

    Signature data:

    • Import gene expression signatures from experiments
    • Select appropriate pathway databases and annotations
    • Configure analysis parameters and thresholds
    • Preview signature quality and coverage

    Analysis configuration

    Pathway selection:

    • Choose from curated pathway databases (GO, KEGG, Reactome)
    • Upload custom pathway definitions and gene sets
    • Select pathway categories relevant to research question
    • Configure pathway size and enrichment thresholds

    Scoring parameters:

    • Statistical methods: Choose enrichment analysis approaches
    • Significance thresholds: Set p-value and FDR cutoffs
    • Scoring algorithms: Select pathway impact calculation methods
    • Confidence filters: Apply quality thresholds for results

    Results visualization and exploration

    Pathway impact maps:

    • Heatmap visualization: Compound-pathway interaction matrices
    • Network diagrams: Pathway relationships and compound connections
    • Enrichment plots: Statistical significance representations
    • Target-pathway linkages: Molecular to biological effect mapping

    Compound ranking:

    • Pathway-based prioritization: Rank compounds by pathway relevance
    • Mechanism clustering: Group compounds by similar pathway effects
    • Selectivity analysis: Assess pathway selectivity vs. promiscuity
    • Safety profiling: Identify potential toxicity pathways

    Interactive exploration:

    • Pathway details: Drill down into specific pathway mechanisms
    • Compound profiles: View detailed pathway effects for individual compounds
    • Comparative analysis: Side-by-side comparison of compound profiles
    • Export capabilities: Generate reports and visualizations

    Integration with .bloom* ecosystem

    Upstream data sources

    Compound data:

    • Virtual screening: Hits from DiffDock and molecular docking
    • Generative chemistry: Compounds from DeepPurpose and AiZynthFinder
    • Experimental data: HTS results and phenotypic screening
    • Literature mining: Compound-target associations from publications

    Biological data:

    • Gene expression: Transcriptomics data from experiments
    • Target databases: Protein target annotations and interactions
    • Pathway databases: Curated biological pathway collections
    • Omics data: Multi-omics datasets for comprehensive analysis

    Downstream applications

    Drug design:

    • Mechanism-guided optimization: Use pathway insights for SAR
    • Target selection: Identify optimal targets based on pathway effects
    • Combination therapy: Assess synergistic pathway combinations
    • Biomarker identification: Link pathway effects to clinical endpoints

    Experimental planning:

    • Assay development: Design pathway-specific functional assays
    • Animal models: Select relevant disease models based on pathways
    • Clinical trials: Identify pathway biomarkers for patient stratification
    • Translational research: Bridge preclinical to clinical pathway effects

    Analysis quality and performance

    Data quality assurance

    Input validation:

    • Compound verification: Validate chemical structures and identifiers
    • Target validation: Check protein target annotations and quality
    • Signature assessment: Evaluate gene expression data quality
    • Pathway verification: Confirm pathway definitions and gene sets

    Analysis reliability:

    • Statistical robustness: Assess enrichment analysis significance
    • Biological relevance: Validate pathway assignments and mechanisms
    • Prediction confidence: Provide uncertainty estimates for results
    • Cross-validation: Compare results across different methods

    Performance optimization

    Computational efficiency:

    • Batch processing: Analyze multiple compounds simultaneously
    • Parallel computation: Utilize distributed processing capabilities
    • Memory optimization: Handle large pathway databases efficiently
    • Result caching: Speed up repeated analyses

    Scalability considerations:

    • Large datasets: Process thousands of compounds and pathways
    • High-throughput screening: Analyze screening libraries efficiently
    • Real-time analysis: Provide immediate results for interactive exploration
    • Resource management: Optimize for different computational environments

    Best practices for pathway analysis

    Data preparation

    Compound curation:

    • Ensure consistent compound identifiers across datasets
    • Validate target annotations with current databases
    • Include relevant physicochemical properties for context
    • Document compound sources and quality information

    Signature quality:

    • Use high-quality gene expression data with appropriate controls
    • Apply appropriate normalization and quality control measures
    • Consider batch effects and technical variability
    • Document experimental conditions and biological context

    Analysis configuration

    Pathway selection:

    • Choose pathway databases relevant to therapeutic area
    • Consider pathway size and specificity for analysis goals
    • Include both general and specific pathway categories
    • Validate pathway definitions against current knowledge

    Parameter optimization:

    • Set appropriate statistical thresholds for significance
    • Consider multiple testing corrections for large analyses
    • Balance sensitivity and specificity based on research goals
    • Document parameter choices for reproducibility

    Result interpretation

    Biological context:

    • Interpret results in context of known biology and disease mechanisms
    • Consider tissue and cell type specificity of pathway effects
    • Account for species differences in pathway conservation
    • Cross-reference with literature and experimental data

    Statistical considerations:

    • Understand p-value and enrichment score interpretations
    • Consider pathway size effects on statistical significance
    • Account for multiple testing in result interpretation
    • Validate key findings with orthogonal approaches

    Research reproducibility

    Documentation:

    • Record all analysis parameters and data sources
    • Document pathway database versions and definitions
    • Preserve analysis workflows for replication
    • Generate comprehensive analysis reports

    Collaboration:

    • Share pathway analysis results with team members
    • Generate publication-ready figures and tables
    • Document methods for peer review and validation
    • Maintain searchable analysis archives

    FAQ

    Was this page helpful?

    Loading...